Clin2
NCT06972537Likely a fitRecruiting

Piperacillin-Tazobactam Dosing for Pneumonia in Older Adults

Pneumonia

Part of Infections, Lungs & breathing clinical trials.

This study looks at the best way to give the antibiotic piperacillin-tazobactam (Zosyn) to people 65 and older who have pneumonia. It aims to make treatment more effective and safer for older adults.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
42 people
Ages
65 years to 100 years
Study type
Interventional

Who can take part

  • You are 65 years old or older.
  • You have been diagnosed with pneumonia.
  • You are currently receiving the antibiotic piperacillin-tazobactam (Zosyn) through an IV.
  • You are not allergic to penicillin or similar antibiotics.
  • You do not need continuous dialysis (CRRT) and have no severe organ failure.
  • You do not have an active cancer.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06977165Not yet recruiting
Study on sepsis types and antibiotics for severe pneumonia

This study looks at different types of sepsis in patients with severe pneumonia. It aims to see how the type of sepsis affects treatment with a common antibiotic called piperacillin/tazobactam.

Manchester, Lancashire
NCT06076200Recruiting
How Piperacillin/Tazobactam works in pregnant women and newborns

This study looks at how the antibiotic Piperacillin/Tazobactam moves through the body of pregnant women and their newborns. It may help doctors decide the best dose to prevent infections in babies at risk.

Jinan
NCT07481539Recruiting· Phase 2
Antibiotic shot for severe infections vs. IV method

This study compares a new way of giving the antibiotic piperacillin/tazobactam: a shot under the skin every few hours instead of through an IV line. It is for hospital patients with severe infections who need this medicine continuously.

Udine, Italia/UD
NCT07494981Not yet recruiting
Precision Antibiotic Dosing in Older Adults

This trial tests a personalized way of giving a strong antibiotic (ceftazidime-avibactam) to older adults. Doctors adjust the dose based on your own body's handling of the drug, aiming to make treatment safer and more effective.

NCT07167524Not yet recruiting
Piperacillin-tazobactam removal during kidney replacement therapy in ICU

This study looks at how well a continuous kidney replacement therapy removes a common antibiotic combination (piperacillin and tazobactam) from the blood in intensive care patients. It may help doctors better dose the antibiotic for patients on this type of dialysis.

Rouen
NCT04436991Recruiting
Testing antibiotic doses in older adults in the emergency room

This study looks at how best to dose certain antibiotics in people age 75 and older who are admitted to a geriatric (older-adult) hospital unit. It aims to measure antibiotic levels in the body to see whether dosing can be improved for older patients.

Ghent

Hear when a new Pneumonia trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.